The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Slit2, a potentially powerful anti-inflammatory agent, inhibits polarization and chemotaxis, but not random movement, of primary neutrophils towards diverse chemoattractants, in vitro and in vivo. In inflammatory diseases, circulating neutrophils are recruited to sites of injury. Attractant signals are provided by many different chemotactic molecules, such that blockade of one may not prevent neutrophil recruitment effectively. The Slit family of secreted proteins and their transmembrane receptor, Robo, repel axonal migration during CNS development. Emerging evidence shows that by inhibiting the activation of Rho-family GTPases, Slit2/Robo also inhibit migration of other cell types toward a variety of chemotactic factors in vitro and in vivo. The role of Slit2 in inflammation, however, has been largely unexplored. We isolated primary neutrophils from human peripheral blood and mouse bone marrow and detected Robo-1 expression. Using video-microscopic live cell tracking, we found that Slit2 selectively impaired directional migration but not random movement of neutrophils toward fMLP. Slit2 also inhibited neutrophil migration toward other chemoattractants, namely C5a and IL-8. Slit2 inhibited neutrophil chemotaxis by preventing chemoattractant-induced actin barbed end formation and cell polarization. Slit2 mediated these effects by suppressing inducible activation of Cdc42 and Rac2 but did not impair activation of other major kinase pathways involved in neutrophil migration. We further tested the effects of Slit2 in vivo using mouse models of peritoneal inflammation induced by sodium periodate, C5a, and MIP-2. In all instances, Slit2 reduced neutrophil recruitment effectively (P<0.01). Collectively, these data demonstrate that Slit2 potently inhibits chemotaxis but not random motion of circulating neutrophils and point to Slit2 as a potential new therapeutic for preventing localized inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Indeed, some chemokine receptor antagonists or blocking antibodies have shown success in animal models and are undergoing clinical trials [6].”
BackgroundHematopoietic Cell Regulation by Rac1 and Rac2 Guanosine Triphosphatases
Gu, Y., Filippi, M.-D., Cancelas, J. A., Siefring, J. E., Williams, E. P., Jasti, A. C., Harris, C. E., Lee, A. W., Prabhakar, R., Atkinson, S. J., et al. (2003) · Science · doi:10.1126/science.1088485 · Cited by 510 · cited 14×
“ME, 5 mM ATP, and pH 7.4, CV column volume(s), DAPI 4 ,6- EBNA1 EBV nuclear antigen 1, EM-CCD electron multiplying charged-coupled device camera, Ena Enabled, FPLC fast performance liquid chromatography, HEK human embryonic kidney, lysis buffer 50 mM Tris, pH 7.5, 10% glycerol, 100 mM NaCl, 1% NP-40, 5 mM MgCl2, 1 mM…”
BackgroundInfluentialJones, C. A., London, N. R., Chen, H., Park, K. W., Sauvaget, D., Stockton, R. A., Wythe, J. D., Suh, W., Larrieu-Lahargue, F., Mukouyama, Y.-S., et al. (2008) · Nature Medicine · doi:10.1038/nm1742 · Cited by 392 · cited 2×
“In vivo, Slit2 inhibits neoangiogenesis by impairing pathologic migration of endothelial cells to vascular endothelial growth factor [18].”
How is actin polymerization nucleated in vivo?
Condeelis, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02008-6 · Cited by 258 · cited 1×
“We directly assayed the effects of Slit2 on actin free barbed end formation, an event critical for formation of protruding lamellipodia and neutrophil migration [21, 37, 43-46].”
Method
Cited by
The principles of directed cell migration
SenGupta, S., Parent, C. A., & Bear, J. E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00366-6 · Cited by 669
Corneal nerves in health and disease
Shaheen, B. S., Bakir, M., & Jain, S. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.09.002 · Cited by 474
Novel roles for Slits and netrins: axon guidance cues as anticancer targets?
Mehlen, P., Delloye-Bourgeois, C., & Chédotal, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3005 · Cited by 275
Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis
He, X., Tolosa, M. F., Zhang, T., Goru, S. K., Ulloa Severino, L., Misra, P. S., McEvoy, C. M., Caldwell, L., Szeto, S. G., Gao, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146243 · Cited by 106
Chan, K. L., Tam, T. H., Boroumand, P., Prescott, D., Costford, S. R., Escalante, N. K., Fine, N., Tu, Y., Robertson, S. J., Prabaharan, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.027 · Cited by 88
Self-citationClark, S. L., Chan, R., Zhao, M., Xie, L. Y., Copeland, W. E., Aberg, K. A., & van den Oord, E. J. C. G. (2021) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2021.02.008 · Cited by 23
Coleman, D. J., Garcia, G., Hyter, S., Jang, H. S., Chagani, S., Liang, X., Larue, L., Ganguli-Indra, G., & Indra, A. K. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004321 · Cited by 17
Metadata
- Authors
- Tole, S., Mukovozov, I. M., Huang, Y.-W., Magalhaes, M. A. O., Yan, M., Crow, M. R., Liu, G. Y., Sun, C. X., Durocher, Y., Glogauer, M., & Robinson, L. A.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-16
- Volume
- 86
- Issue
- 6
- Pages
- 1403-1415
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2009743745
- Cited by
- 87
- References
- 4
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.